Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-20

FDA Approved: OXCARBAZEPINE — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's original application for oxcarbazepine, a generic antiepileptic drug, for the treatment of partial-onset seizures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

ORIG AP for OXCARBAZEPINE (OXCARBAZEPINE)